News and Commentary Archive

Explore recent scientific discoveries and news as well as CLBB events, commentary, and press.

Mission

The speed of technology in neuroscience as it impacts ethical and just decisions in the legal system needs to be understood by lawyers, judges, public policy makers, and the general public. The Massachusetts General Hospital Center for Law, Brain, and Behavior is an academic and professional resource for the education, research, and understanding of neuroscience and the law. Read more

WATCH — Battling Blood in the Streets

2016.09.07_battling_blood_for_print

Click poster to enlarge.

Far too many people across the country are left dead, injured, or traumatized by community violence. Communities can be safer when neuroscience, public health strategies, and collective advocacy are aligned in practice and policy. What are the best next steps to fostering a broad science-informed advocacy movement to effectively address community violence? The event took place at 4:00 pm on Wednesday, September 7th, in Wasserstein Hall, Room 1010 at Harvard Law School (1585 Massachusetts Avenue, Cambridge, MA).

The event was free and open to the public, and was followed by the Petrie-Flom Center’s 2016 Open House.

Continue reading »

Synaptic Gap: 21st Century Brain Science Meets Mental Health Treatment and Policy

CLBB Co-Director Dr. Judith Edersheim will be one of the featured speakers at “Synaptic Gap: 21st Century Brain Science Meets Mental Health Treatment and Policy“, a HUBweek 2016 event that will explore ways to connect the latest advances in neuroscience with mental health treatment and policy. She will be interviewed by award-winning Boston Globe columnist Kevin Cullen.

The event will take place on Wednesday, September 28th from 7:30am – 4:30pm at Starr Center, 185 Cambridge Street, 2nd Floor.

Make sure to register for the event here!
Continue reading »

Neuroscience and Behavioral Genetics in US Criminal Law: An Empirical Analysis

By Nita Farahany | Journal of Law and the Biosciences | January 14, 2016

Abstract:

The goal of this study was to examine the growing use of neurological and behavioral genetic evidence by criminal defendants in US criminal law. Judicial opinions issued between 2005–12 that discussed the use of neuroscience or behavioral genetics by criminal defendants were identified, coded and analysed. Yet, criminal defendants are increasingly introducing such evidence to challenge defendants’ competency, the effectiveness of defense counsel at trial, and to mitigate punishment.

Read the entire paper here.

Changes in Seasons, Changes for Children

By Robert Kinscherff, Senior Fellow in Law & Applied Neuroscience

It is fitting that I am writing this first blog of my time as Senior Fellow in Law and Applied Neuroscience as we transition through the change of seasons.  It is a privilege to have the time afforded by this joint Fellowship between Harvard Law School (Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics) and Massachusetts General Hospital (Center for Law, Brain, and Behavior) to focus upon the intersections of behavioral science, developmental neuroscience, and juvenile justice.  The autumnal change of seasons is a fitting metaphor for the slow but profound changes occurring in juvenile justice which have been spurred in large measure by emerging neuroscience increasingly describing the neurobiology of adolescence.  This neuroscience provides the biological complement to what developmental psychologists have well described and what parents have long known:  Children are different. Continue reading »

Steve Hyman on Translational Neuroscience

Hyman_150x150Steven Hyman is a co-editor of the new book, Translational Neuroscience: Toward New Therapies, published by the MIT Press. This volume, composed of insights from expert contributors, takes a look at the current state of translational neuroscience, challenges it faces, and effective ways forward. In overview:

Today, translational neuroscience faces significant challenges. Available therapies to treat brain and nervous system disorders are extremely limited and dated, and further development has effectively ceased. Disinvestment by the private sector occurred just as promising new technologies in genomics, stem cell biology, and neuroscience emerged to offer new possibilities. In this volume, experts from both academia and industry discuss how novel technologies and reworked translation concepts can create a more effective translational neuroscience.

The contributors consider such topics as using genomics and neuroscience for better diagnostics and biomarker identification; new approaches to disease based on stem cell technology and more careful use of animal models; and greater attention to human biology and what it will take to make new therapies available for clinical use. They conclude with a conceptual roadmap for an effective and credible translational neuroscience—one informed by a disease-focused knowledge base and clinical experience.

Dr. Hyman is also a featured contributor to the new book, Free Will and the Brain: Neuroscientific, Philosophical, and Legal Perspectives, edited by Walter Glannon and published by Cambridge University Press. His chapter, “Neurobiology Collides with Moral and Criminal Responsibility: The Result is Double Vision”, falls under Part V of the book, dealing with the legal implications of neuroscience, and including a chapter from Dr. Stephen Morse.

Order Translational Neuroscience: Toward New Therapies and Free Will and the Brain today!